Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

In certain types of cancer, PPARγ can contribute to tumor growth or metabolic changes. The drug, pioglitazone, is a so-called agonist that binds to a PPARy receptor and activates it. Thereby it ...

Balancing best practices with patient affordability and literacy. Here’s how one doctor adapts treatment plans for real-world ...

First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

Thankfully, with a bit more walking and some diet changes, like swapping white bread and pasta for wholemeal and making my ...

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

Virtual visits and remote monitoring are redefining how patients manage chronic conditions—boosting access, engagement, and outcomes.

In a study of older adult women with diabetes led by UC San Diego researchers, metformin, a widely used diabetes medication, ...

Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...

If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key ...